7 days ago
NBIX
AnalystsDanielle BrillDanielle Brill's Stock Forecasts
AnalystsDanielle Brill
Analyst Ranking
Top 8%
#431 out of 5326 analysts
Average Return
+20.35%
Win Rate
51%55 out of 108
Risk vs Reward
Poor
Good
Danielle Brill's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Uniqure NvQURE | +1,074.35% | $5.42 | $63.65 | 2024-10-10 - 2025-10-09 | Buy |
Palvella Therapeutics IncPVLA | +407.23% | $31.00 | $157.24 | 2025-07-21 - 2026-07-17 | Strong Buy |
Dianthus Therapeutics IncDNTH | +197.09% | $35.55 | $105.60 | 2025-10-14 - 2026-07-17 | Strong Buy |
Dianthus Therapeutics IncDNTH | +177.02% | $38.12 | $105.60 | 2026-01-08 - 2026-07-17 | Strong Buy |
Centessa Pharmaceuticals PLCCNTA | +152.18% | $16.06 | $40.50 | 2025-07-21 - 2026-06-26 | Strong Buy |
Danielle Brill Analyst Color
Get additional color on Danielle Brill's coverage of popular stocks
2 months ago
RAPP
2 months ago
PRAX
2 months ago
NBIX
3 months ago
BBIO
4 months ago
DNTH
5 months ago
BBIO
5 months ago
NBIX
6 months ago
CNTA
6 months ago
ARGX
6 months ago
NBIX
6 months ago
DNTH
6 months ago
CNTA
6 months ago
BBIO
7 months ago
PVLA
8 months ago
IRON
9 months ago
BBIO
9 months ago
ALNY
10 months ago
PVLA
2 years ago
SRPT
Danielle Brill's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vertex Pharmaceuticals IncVRTX | 2 | Strong Buy | $560.00 | +15.31% | Maintains | 7 days ago |
Neurocrine Biosciences IncNBIX | 11 | Strong Buy | $200.00 | +17.04% | Maintains | 7 days ago |
Alnylam Pharmaceuticals IncALNY | 5 | Strong Buy | $410.00 | +53.29% | Maintains | 7 days ago |
Biogen IncBIIB | 2 | Strong Buy | $235.00 | +14.08% | Upgrades | 7 days ago |
Praxis Precision Medicines IncPRAX | 2 | Strong Buy | $616.00 | +95.92% | Maintains | 2 months ago |
Apogee Therapeutics IncAPGE | 2 | Hold | $81.00 | -39.55% | Maintains | 2 months ago |
Immunovant IncIMVT | 7 | Hold | $30.00 | -25.48% | Maintains | 2 months ago |
Rapport Therapeutics IncRAPP | 1 | Strong Buy | $56.00 | +31.39% | Assumes | 2 months ago |
Insmed IncINSM | 1 | Strong Buy | $185.00 | +70.79% | Maintains | 2 months ago |
Harmony Biosciences Holdings IncHRMY | 10 | Hold | $29.00 | -14.12% | Maintains | 2 months ago |
Wave Life Sciences LtdWVE | 1 | Strong Buy | $15.00 | +157.73% | Maintains | 3 months ago |
Bridgebio Pharma IncBBIO | 5 | Strong Buy | $102.00 | +25.34% | Maintains | 3 months ago |
Maze Therapeutics IncMAZE | 2 | Strong Buy | $64.00 | +127.60% | Maintains | 3 months ago |
Climb Bio IncCLYM | 1 | Strong Buy | $17.00 | +33.86% | Initiates Coverage On | 4 months ago |
Dianthus Therapeutics IncDNTH | 3 | Strong Buy | $110.00 | +4.17% | Maintains | 4 months ago |
Disc Medicine IncIRON | 7 | Strong Buy | $83.00 | +9.00% | Maintains | 5 months ago |
Centessa Pharmaceuticals PLCCNTA | 3 | Strong Buy | $38.00 | -6.17% | Maintains | 6 months ago |
Argenx SeARGX | 8 | Strong Buy | $1,030.00 | +19.69% | Maintains | 6 months ago |
Tectonic Therapeutic IncTECX | 3 | Strong Buy | $60.00 | +84.05% | Maintains | 6 months ago |
Palvella Therapeutics IncPVLA | 4 | Strong Buy | $190.00 | +20.83% | Maintains | 7 months ago |
Upstream Bio IncUPB | 1 | Strong Buy | $47.00 | +570.47% | Initiates Coverage On | 9 months ago |
Jefferson Capital IncJCAP | 1 | Strong Buy | $24.00 | +22.82% | Initiates Coverage On | a year ago |
Uniqure NvQURE | 6 | Strong Buy | $52.00 | N/A | Upgrades | 2 years ago |
Biomarin Pharmaceutical IncBMRN | 1 | Buy | $79.00 | N/A | Reinstates | 2 years ago |
Regenxbio IncRGNX | 1 | Buy | $18.00 | N/A | Reinstates | 2 years ago |
Sarepta Therapeutics IncSRPT | 2 | Buy | $150.00 | N/A | Reinstates | 2 years ago |
Xenon Pharmaceuticals IncXENE | 2 | Buy | $50.00 | N/A | Reinstates | 2 years ago |
Agios Pharmaceuticals IncAGIO | 2 | Buy | $51.00 | N/A | Reinstates | 2 years ago |
Passage Bio IncPASG | 5 | Buy | $100.00 | N/A | Maintains | 3 years ago |
Ptc Therapeutics IncPTCT | 6 | Buy | $55.00 | N/A | Maintains | 3 years ago |
Kyntra Bio IncKYNB | 2 | Buy | $875.00 | N/A | Upgrades | 3 years ago |
Acceleron Pharma IncXLRN | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Acadia Pharmaceuticals IncACAD | 2 | Buy | $35.00 | N/A | Downgrades | 5 years ago |
Global Blood Therapeutics IncGBT | 4 | Hold | $50.00 | N/A | Downgrades | 6 years ago |
Gw Pharmaceuticals PLCGWPH | 1 | Hold | N/A | N/A | Initiates Coverage On | 6 years ago |
Zogenix IncZGNX | 1 | Hold | N/A | N/A | Initiates Coverage On | 6 years ago |
Alder Biopharmaceuticals IncALDR | 2 | Buy | $28.00 | N/A | Assumes | 8 years ago |
Sage Therapeutics IncSAGE | 1 | Buy | $82.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.